"The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-In" by Charles L Bennett, Sumimasa Nagai et al.
 

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions.

Document Type

Journal Article

Publication Date

8-1-2021

Journal

The Oncologist

Volume

26

Issue

8

Inclusive Pages

e1418-e1426

DOI

10.1002/onco.13713

Comments

Epub 2021 Mar 12

Peer Reviewed

1

Find in your library

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 1
  • Usage
    • Abstract Views: 23
  • Captures
    • Readers: 30
  • Mentions
    • News Mentions: 3
  • Social Media
    • Shares, Likes & Comments: 37
see details

Share

COinS